Here’s the latest update from Roger Seheult, MD, co-founder and instructor at MedCram. Dr. Seheult is an Associate Clinical Professor at the University of California, Riverside School of Medicine and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SGLT2 inhibitors do not reduce risk for death or other ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. PCSK9 inhibitors may best be known for their powerful LDL-lowering effects but are less appreciated ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days ...
Scientists discover novel series of SARS-CoV-2 mpro inhibitors for potential new COVID-19 treatments
New research has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback